Endowment / Foundation

Updated:

Research to Prevent Blindness Endowment Fund

The Research to Prevent Blindness Endowment Fund Inc. was established in 1988 as a tax-exempt support organization. Its purpose is to manage assets that...

Research to Prevent Blindness Endowment Fund logo

Research to Prevent Blindness Endowment Fund

The Research to Prevent Blindness Endowment Fund Inc. was established in 1988 as a tax-exempt support organization. Its purpose is to manage assets that generate grants for scientific research on eye diseases. Jules Stein founded the parent Research to Prevent Blindness organization in 1960. The fund allocates across public equities, corporate bonds, core real estate through Mercer, emerging markets equity via DFA, and a commodities fund. It also holds limited partner interests in private equity and private credit vehicles. Geographic exposure centers on the United States with additional holdings in global and emerging markets. Confirmed positions include the Mercer US Core Real Estate Portfolio and DFA Emerging Markets Portfolio. The organization employs no disclosed investment staff count. It maintains its headquarters lease at 360 Lexington Avenue in New York. Service providers include Sassetti LLC as auditor and GlobeOp for fund administration. No operational investment events from the last 24 months appear in available records. The endowment functions strictly as a grant-making vehicle subordinate to Research to Prevent Blindness, Inc. Its board overlaps with the parent entity while separate financial statements govern asset management and distributions.

General information

Firm type

Endowment / Foundation

Year founded

1988

Location

Region

North America

Country

United States

City

New York

Corporate office

360 Lexington Avenue 22nd Floor, New York, NY 10017, United States

Principals

Brian F. Hofland

President

Diane S. Swift

Chairman of the Board of Trustees

David Brenner

Vice President and Secretary

John Tinker

Treasurer and Assistant Secretary

Sector focus

Healthcare

Frequently asked questions

Who runs investment decisions at Research to Prevent Blindness Endowment Fund?

Brian F. Hofland serves as president. Diane S. Swift chairs the board of trustees. Day-to-day investment oversight relies on external advisors including Mercer.

Does the fund participate in fund commitments or only direct deals?

The endowment holds limited partner interests in private equity and private credit funds. It also maintains direct positions in public stocks, bonds, and a core real estate portfolio.

Where does the underlying wealth come from?

The endowment was seeded to support Research to Prevent Blindness, Inc., the organization founded by Jules Stein in 1960. No individual family wealth source is disclosed.

What asset classes appear in the portfolio?

Holdings include public equities, corporate bonds, core real estate, emerging markets equity, commodities, and private fund commitments.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More New York Endowment / Foundation profiles